The chemical class known as Vmn2r26 activators encompasses a diverse range of compounds that can engage with the cellular signaling pathways to activate the Vmn2r26 protein, a member of the G protein-coupled receptor (GPCR) family. These activators operate by modulating various components of the intracellular machinery that either directly or indirectly influence the signaling cascades involving Vmn2r26. Activation of such pathways can result from the upregulation of secondary messengers such as cyclic AMP (cAMP), alterations in calcium ion concentrations within the cell, or modulation of protein kinases that play a role in receptor phosphorylation and subsequent signal transduction. The action of these activators is not isolated to Vmn2r26; they can affect a multitude of receptors and enzymes associated with the GPCR system. This broad activity stems from their ability to influence universal cellular messengers and regulators that are shared across numerous receptor-mediated processes.
The specificity of these activators is not highly refined, meaning their influence extends to a variety of receptors and signaling mechanisms. The bioactivity of these compounds involves either the enhancement of the signaling molecules that promote Vmn2r26 activity or the inhibition of those that restrain it. For instance, certain activators can elevate the levels of cAMP, a pivotal second messenger in GPCR signaling, thereby amplifying the response of Vmn2r26. Others can modulate protein kinases that are integral to the phosphorylation events necessary for receptor activation. Additionally, some activators can alter the balance of intracellular calcium, a critical ion that influences numerous signaling pathways, including those associated with Vmn2r26. By shifting the dynamics of these key cellular constituents, Vmn2r26 activators can orchestrate a cellular environment conducive to the activation of Vmn2r26, thereby facilitating its role in signal transmission.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which can phosphorylate proteins within GPCR pathways, and this action can activate Vmn2r26. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective phosphodiesterase inhibitor that prevents cAMP breakdown, enhancing signaling through GPCRs that can activate Vmn2r26. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inactivates certain G proteins, affecting the balance of signaling through GPCRs, which can activate Vmn2r26. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium levels, which can activate many GPCR pathways including potentially Vmn2r26. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
A Ca2+/calmodulin-dependent kinase II inhibitor, which could modulate downstream effects of GPCR activation, potentially activating Vmn2r26. | ||||||